Author

Jørgen Jahnsen 1

1 University of Oslo/Akershus University Hospital,Oslo,Norway

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Raja Atreya, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie Lees, Edouard Louis, Milan Lukas, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun

BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY

Joachim Høg Mortensen, Aida Kapic Lunder, Tina Manon-Jensen, Morten Asser Karsdal, Mette Juul Nielsen, Diana Julie Leeming, Johannes Roksund Hov, Anne Negård, Jørgen Jahnsen, Bjørn A Moum, Mette Vesterhus, Marte Lie Hoivik, Vendel A. Kristensen

BIOSIMILAR INFLIXIMAB (CT-P13) IS NOT INFERIOR TO ORIGINATOR INFLIXIMAB: EXPLORATIVE SUBGROUP-ANALYSES IN CROHN’S DISEASE AND ULCERATIVE COLITIS IN THE NOR-SWITCH EXTENSION TRIAL  

Kristin Kaasen Kaasen Jørgensen, Guro L Goll, Joe Sexton, Inge C Olsen, Nils Bolstad, Knut E.A. Lundin, Ingrid P Berset, Espen A Haavardsholm, Cato Mørk, Tore K Kvien, Jørgen Jahnsen

BIOSIMILAR INFLIXIMAB (CT-P13) IS NOT INFERIOR TO ORIGINATOR INFLIXIMAB: RESULTS FROM THE 52-WEEK RANDOMIZED NOR-SWITCH TRIAL

Kristin K Jørgensen, Inge C Olsen, Guro L Goll, Merete Lorentzen, Nils Bolstad, Espen A Haavardsholm, Knut E.A. Lundin, Cato Mørk, Jørgen Jahnsen, Tore K Kvien

COMPREHENSIVE CIRCULATORY TRANSCRIPTOME AND PROTEOMIC PROFILING IN NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES: A MULTI-CENTRE COHORT STUDY  

Rahul Kalla, AleT Adams, Jonas Lindstrom, Morten Harald Vatn, Jørgen Jahnsen, Petr Ricanek, Daniel Bergemalm, Johan D. Söderholm, Marieke J. Pierik, Fernando Gomollon Garcia, Mauro D'Amato, Jonas Halfvarson, Jack Satsangi

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

DYSBIOSIS OF THE GUT MICROBIOTA IN RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

Petr Ricanek, Rahul Kalla, Yolanda Ber, simen vatn, Magdalena Kauczynska Karlsson, Lene Finnby, Daniel Bergemalm, Adam Carstens, Johan D. Söderholm, Jørgen Jahnsen, Fernando Gomollón, Jonas Halfvarson, Jack Satsangi, Christina Casén, Morten Harald Vatn

EPIGENETIC ALTERATIONS IN INFLAMMATORY BOWEL DISEASE - THE INFLUENCE OF GERMLINE VARIATION (MEQTLS) ON GENOME-WIDE METHYLATION ALTERATIONS.

AleT Adams, Rahul Kalla, Elaine R Nimmo, Morten Harald Vatn, Jørgen Jahnsen, Petr Ricanek, Jonas Halfvarson, Johan D. Söderholm, Marieke J. Pierik, Fernando Gomollon Garcia, Ivo G. Gut, Mauro D'Amato, Jack Satsangi

MICROBIOTA ALTERATIONS IN TREATMENT NAÏVE IBD AND NON-IBD PATIENTS - THE EU IBD-CHARACTER PROJECT

Petr Ricanek, simen vatn, Rahul Kalla, Yolanda Ber, Ewa Ciemniejewska, Marieke J. Pierik, Jonas Halfvarson, Johan D. Söderholm, Jørgen Jahnsen, Fernando Gomollon Garcia, Jack Satsangi, Morten Harald Vatn, Monika Sekelja, Christina Casén

PATIENTS PERCEPTIONS OF QUALITY OF CARE AND FOLLOW-UP IN INFLAMMATORY BOWEL DISEASE

Lars-Petter Jelsness-Jørgensen, Marte Lie Høivik, Svein Oskar Frigstad, Tore Grimstad, Ingrid Prytz Berset, Gert Huppertz-Hauss, Øistein Hovde, Roald Torp, Jørgen Jahnsen, Tomm Bernklev, Bjorn Moum

Item 1 - 10 / 14
1
2